Company Filing History:
Years Active: 2011-2016
Title: The Innovations of Theresa Swift-Scanlan
Introduction
Theresa Swift-Scanlan is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of molecular diagnostics, particularly in cancer detection. With a total of 3 patents, her work has the potential to revolutionize how certain conditions are diagnosed.
Latest Patents
One of her latest patents is focused on a method known as Quantitative multiplex methylation-specific PCR. This innovative technique provides methods for diagnosing conditions such as carcinoma, sarcoma, or leukemia, which are associated with hypermethylation of genes. The method allows for the isolation of genes from tissue samples containing as few as 50 to 1000 tumor cells. By utilizing quantitative multiplex methylation-specific PCR (QM-MSP), multiple genes can be quantitatively evaluated from samples that typically yield sufficient DNA for the analysis of only one or two genes. The DNA sequences isolated from the sample are co-amplified in an initial multiplex round of PCR. Subsequently, the methylation status of individual hypermethylation-prone gene promoter sequences is determined separately or in multiplex using a real-time PCR round that is methylation status-specific. This method not only determines the level of promoter hypermethylation but also assesses the incidence of promoter hypermethylation, allowing for a cumulative scoring of the genes in the panel. The QM-MSP method is also adaptable for high-throughput automated technology.
Career Highlights
Theresa is affiliated with The Johns Hopkins University, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on early cancer detection and treatment strategies.
Collaborations
Some of her notable coworkers include Saraswati Vaidyanathan Sukumar and Mary Jo Fackler, who contribute to her research endeavors.
Conclusion
Theresa Swift-Scanlan's innovative work in molecular diagnostics exemplifies the critical role of inventors in advancing medical technology. Her contributions are paving the way for more effective cancer diagnosis and treatment options.